Skip to main content
. 2018 May 9;13(5):e0197061. doi: 10.1371/journal.pone.0197061

Fig 2. Pharmacokinetics of SNF472 after intravenous (A, B) and subcutaneous (C, D) bolus administration and intravenous infusion into rats (E-G).

Fig 2

Phytate levels quantified in plasma samples of control Wistar rats after intravenous (A) and subcutaneous (C) bolus administration (N = 3) and in control and uremic Wistar rats after intravenous infusion of 10 mg/kg (E) and 50 mg/kg SNF472 (F) (N = 5). Results are expressed as means ± SD. Dose-exposure relationship after intravenous (B) and subcutaneous (D) bolus administration and after intravenous infusion (G).